FTH CIK: 1829802

Faeth Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.3
FY22:
−39.0
FY23:
−32.0
FY24:
−24.7
FY25:
−20.5
Change from FY21 to FY25
millions USD
FY21:
−143
FY22:
49.9
FY23:
38.4
FY24:
22.4
FY25:
19.8
Change from FY21 to FY25
millions USD
FY21:
164
FY22:
−0.29
FY23:
−11.2
FY24:
−0.79
FY25:
−0.65
millions USD
FY21:
−9.44
FY22:
10.6
FY23:
−4.78
FY24:
−3.02
FY25:
−1.33
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.3
FY22:
−39.3
FY23:
−32.2
FY24:
−24.8
FY25:
−20.5

All amounts in millions USD Data source:SEC EDGAR